Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
<p>Abstract</p> <p>Background</p> <p>Development of therapies for patients with BRCA1 mutations has been hampered by lack of readily available <it>in vitro </it>and <it>in vivo </it>models. We recently showed that transplantation of transgenic ma...
Main Authors: | Anver Miriam R, Hollingshead Melinda G, Herschkowitz Jason I, Robles Ana I, Wright Mollie H, Perou Charles M, Varticovski Lyuba |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-04-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/7/1/29 |
Similar Items
-
A transcriptional response to replication stress selectively expands a subset of Brca2-mutant mammary epithelial cells
by: Maryam Ghaderi Najafabadi, et al.
Published: (2023-08-01) -
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
by: Shafee, Norazizah, et al.
Published: (2008) -
2066 Functional characterization of mutant BRCA1
by: John Barrows, et al.
Published: (2018-06-01) -
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
by: Yanying Huo, et al.
Published: (2021-04-01) -
Unveiling the relationship between WWOX and BRCA1 in mammary tumorigenicity and in DNA repair pathway selection
by: Tirza Bidany-Mizrahi, et al.
Published: (2024-03-01)